Osteogenic Neoplasm — Trials

Osteogenic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

357 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–36 of 36 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04417062	Olaparib With Ceralasertib in Recurrent Osteosarcoma	active not recruiting	Phase 2	49	Dana-Farber Cancer InstituteOTHER	1	Sep 24, 2026	clinicaltrials
NCT03210714	Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)	active not recruiting	Phase 2	20	National Cancer Institute (NCI)NIH	2	Sep 22, 2026